T. Rowe Price Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-104,938	Closed	-$500K	–	577
2023 Q2	$500K	Buy	104,938 +4,858	+5%	+$23.1K	﹤0.01%	546
2023 Q1	$571K	Sell	100,080 -333,789	-77%	-$1.9M	﹤0.01%	542
2022 Q4	$4.38M	Buy	433,869 +27,725	+7%	+$280K	﹤0.01%	527
2022 Q3	$9.1M	Buy	+406,144	New	+$9.1M	0.01%	504